Profile data is unavailable for this security.
About the company
Guardion Health Sciences, Inc. is a clinical nutrition company. The Company offers a portfolio of science-based, clinically supported products designed to support the health needs of consumers, healthcare professionals and providers and their patients. The Company, through Activ Nutritional, LLC (Activ), owns the Viactiv line of supplements for bone health and other applications. The Viactiv line of supplements contains several flavored nutritional supplement products, but the milk chocolate and caramel flavored calcium chews constitute the main product category. It also sells Lumega-Z, its medical food product that has a formula designed to replenish and restore the macular protective pigment, simultaneously delivering critical and essential nutrients to the eye. The Company's GlaucoCetin is a dietary supplement in a capsule form designed specifically to provide nutrients to support mitochondrial function with additional antioxidants to help reduce oxidative stress.
- Revenue in USD (TTM)12.25m
- Net income in USD158.03k
- Incorporated2015
- Employees9.00
- LocationGuardion Health Sciences Inc2925 Richmond Avenue, Suite 1200HOUSTON 77098United StatesUSA
- Phone+0 (1800) 873-5141
- Fax+1 (858) 630-5543
- Websitehttps://www.guardionhealth.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BioNexus Gene Lab Corp | 9.77m | -2.63m | 10.25m | 30.00 | -- | 1.06 | -- | 1.05 | -0.1389 | -0.1389 | 0.6873 | 0.5466 | 0.9703 | 7.98 | 5.33 | -- | -26.11 | -3.83 | -31.86 | -5.02 | 13.61 | 14.55 | -26.91 | -3.04 | 4.24 | -186.19 | 0.00 | -- | -10.60 | 115.07 | -638.56 | -- | 30.40 | -- |
| Mystic Holdings Inc | -100.00bn | -100.00bn | 10.55m | 79.00 | -- | 0.4223 | -- | -- | -- | -- | -- | 0.2155 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.2228 | -- | 0.1849 | -- | 199.82 | -- | 34.32 | -- | -- | -- |
| Viaderma Inc | 17.80m | 2.31m | 10.56m | 75.00 | 0.0005 | 0.00003 | 1.95 | 0.5934 | 16.84 | 16.84 | 129.62 | 255.59 | 0.4126 | 24.69 | 1.21 | 237,331.30 | 5.36 | -- | 6.53 | -- | 28.90 | -- | 12.99 | -- | 2.07 | 5.66 | 0.1718 | -- | -29.15 | -- | -40.70 | -- | -- | -- |
| Guardion Health Sciences Inc | 12.25m | 158.03k | 10.56m | 9.00 | 66.19 | 1.29 | 59.52 | 0.8623 | 0.1243 | 0.1243 | 9.66 | 6.39 | 0.729 | 2.36 | 5.83 | 1,360,951.00 | 0.9405 | -77.90 | 1.12 | -86.55 | 44.04 | 42.45 | 1.29 | -176.93 | 6.98 | -- | 0.00 | -- | 10.85 | 67.03 | 101.00 | -- | -58.56 | -- |
| Moleculin Biotech Inc | 0.00 | -29.77m | 10.60m | 18.00 | -- | 0.4067 | -- | -- | -15.06 | -15.06 | 0.00 | 11.70 | 0.00 | -- | -- | 0.00 | -62.25 | -46.84 | -70.87 | -51.49 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -2.56 | -- | -21.54 | -- |
| BioCardia Inc | 477.00k | -11.57m | 10.64m | 16.00 | -- | -- | -- | 22.30 | -0.5525 | -0.5525 | 0.0225 | -0.0677 | 0.0747 | -- | 3.61 | 29,812.50 | -181.08 | -107.34 | -414.21 | -154.17 | -- | -- | -2,425.79 | -1,779.24 | -- | -- | -- | -- | -64.72 | -5.26 | 2.82 | -- | -28.89 | -- |
| Mira Pharmaceuticals Inc | 0.00 | -11.98m | 10.64m | 3.00 | -- | 2.43 | -- | -- | -0.8314 | -0.8314 | 0.00 | 0.296 | 0.00 | -- | -- | 0.00 | -413.86 | -- | -620.46 | -- | -- | -- | -- | -- | -- | -2.47 | 0.00 | -- | -- | -- | -69.77 | -- | -- | -- |
| Medical Marijuana Inc | -100.00bn | -100.00bn | 10.75m | -- | -- | 0.1157 | -- | -- | -- | -- | -- | 0.019 | -- | -- | -- | -- | -- | -22.66 | -- | -23.11 | -- | 70.58 | -- | -145.52 | 1.79 | -- | 0.0479 | -- | 26.30 | 39.07 | 141.59 | -- | -0.016 | -- |
| Chromocell Therapeutics Corp | 0.00 | -7.38m | 10.76m | 4.00 | -- | -- | -- | -- | -1.28 | -1.28 | 0.00 | -1.12 | 0.00 | -- | -- | 0.00 | -9,746.19 | -- | -- | -- | -- | -- | -- | -- | -- | -13.23 | -- | -- | -- | -- | -200.20 | -- | -- | -- |
| Lotus Pharmaceuticals Inc | 70.79m | 1.72m | 10.81m | 233.00 | 0.0725 | 0.0011 | 2.80 | 0.1526 | 0.0553 | 0.0553 | 2.56 | 3.58 | 0.6321 | 37.27 | 17.85 | 303,836.90 | 1.55 | 22.84 | 1.71 | 26.40 | 35.10 | 41.62 | 2.45 | 19.93 | 0.4428 | 30.80 | 0.0516 | 0.00 | 28.71 | 31.70 | -12.22 | 51.11 | 70.48 | -- |
| Eterna Therapeutics Inc | 68.00k | -21.68m | 10.93m | 8.00 | -- | 4.90 | -- | 160.73 | -4.08 | -4.08 | 0.0128 | 0.4128 | 0.0019 | -- | 0.0988 | 8,500.00 | -60.69 | -169.05 | -75.78 | -223.00 | -173.53 | -- | -31,864.71 | -682.61 | -- | -33.19 | 0.7813 | -- | -- | -68.89 | 11.84 | -- | -58.86 | -- |
| ABVC Biopharma Inc | 152.43k | -10.52m | 11.19m | 16.00 | -- | 1.00 | -- | 73.44 | -2.52 | -2.52 | 0.0352 | 1.06 | 0.0127 | -- | 0.3514 | 9,526.88 | -90.65 | -103.38 | -171.60 | -231.54 | -98.15 | 76.25 | -7,157.57 | -2,019.89 | -- | -3.28 | 0.153 | -- | -84.28 | 85.39 | 35.97 | -- | -- | -- |
| Avalo Therapeutics Inc | 1.93m | -31.54m | 11.22m | 19.00 | -- | 1.19 | -- | 5.83 | -381.36 | -381.36 | 6.94 | 9.11 | 0.0708 | 128.50 | 1.87 | 101,315.80 | -116.06 | -99.64 | -228.35 | -154.42 | 33.25 | 84.69 | -1,638.65 | -613.58 | 1.82 | -5.67 | 0.00 | -- | -89.34 | -22.83 | 24.28 | -- | -22.48 | -- |
| ELEVAI Labs Inc | 1.71m | -4.30m | 11.26m | 18.00 | -- | 2.94 | -- | 6.58 | -0.2482 | -0.2482 | 0.0988 | 0.2208 | -- | -- | -- | 95,143.89 | -- | -- | -- | -- | 66.25 | -- | -251.17 | -- | 3.41 | -41.16 | 0.00 | -- | 123.50 | -- | -138.94 | -- | -- | -- |
Data as of May 10 2024. Currency figures normalised to Guardion Health Sciences Inc's reporting currency: US Dollar USD
17.50%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Great Point Capital LLCas of 05 Apr 2024 | 159.65k | 12.43% |
| Renaissance Technologies LLCas of 31 Dec 2023 | 38.02k | 2.96% |
| The Vanguard Group, Inc.as of 31 Dec 2023 | 14.85k | 1.16% |
| BlackRock Fund Advisorsas of 31 Dec 2023 | 10.03k | 0.78% |
| Tower Research Capital LLCas of 31 Dec 2023 | 1.14k | 0.09% |
| Morgan Stanley & Co. LLCas of 31 Dec 2023 | 659.00 | 0.05% |
| Citigroup Global Markets, Inc. (Investment Management)as of 31 Dec 2023 | 373.00 | 0.03% |
| Cornerstone Planning Group LLCas of 31 Dec 2023 | 37.00 | 0.00% |
| Wells Fargo Bank, NA (Private Banking)as of 31 Dec 2023 | 8.00 | 0.00% |
| Arbor Point Advisors LLCas of 31 Dec 2023 | 6.00 | 0.00% |
More ▼
Data from 31 Dec 2023 - 05 Apr 2024Source: FactSet Research Systems Inc.
